{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:19:50Z","timestamp":1789773590011,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T00:00:00Z","timestamp":1634601600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19fk0108169"],"award-info":[{"award-number":["JP19fk0108169"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009619","name":"the Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP19fk0108110"],"award-info":[{"award-number":["JP19fk0108110"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The COVID-19 pandemic is an unprecedented threat to humanity that has provoked global health concerns. Since the etiopathogenesis of this illness is not fully characterized, the prognostic factors enabling treatment decisions have not been well documented. Accurately predicting the progression of the disease would aid in appropriate patient categorization and thus help determine the best treatment option. Here, we have introduced a proteomic approach utilizing data-independent acquisition mass spectrometry (DIA-MS) to identify the serum proteins that are closely associated with COVID-19 prognosis. Twenty-seven proteins were differentially expressed between severely ill COVID-19 patients with an adverse or favorable prognosis. Ingenuity Pathway Analysis revealed that 15 of the 27 proteins might be regulated by cytokine signaling relevant to interleukin (IL)-1\u03b2, IL-6, and tumor necrosis factor (TNF), and their differential expression was implicated in the systemic inflammatory response and in cardiovascular disorders. We further evaluated practical predictors of the clinical prognosis of severe COVID-19 patients. Subsequent ELISA assays revealed that CHI3L1 and IGFALS may serve as highly sensitive prognostic markers. Our findings can help formulate a diagnostic approach for accurately identifying COVID-19 patients with severe disease and for providing appropriate treatment based on their predicted prognosis.<\/jats:p>","DOI":"10.1038\/s41598-021-98253-9","type":"journal-article","created":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T10:04:50Z","timestamp":1634637890000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Identification of serum prognostic biomarkers of severe COVID-19 using a quantitative proteomic approach"],"prefix":"10.1038","volume":"11","author":[{"given":"Yayoi","family":"Kimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihye","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miyui","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuriko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sousuke","family":"Kubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundararaj Stanleyraj","family":"Jeremiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Ino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayano","family":"Moriyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Saji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideya","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Murohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kouji","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri","family":"Hagiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiko","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeharu","family":"Yamanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihide","family":"Ryo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,19]]},"reference":[{"key":"98253_CR1","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijsu.2020.03.036","volume":"77","author":"C Sohrabi","year":"2020","unstructured":"Sohrabi, C. et al. Corrigendum to \u201cWorld Health Organization declares Global Emergency: A review of the 2019 Novel Coronavirus (COVID-19)\u201d. Int. J. Surg. 77, 217. https:\/\/doi.org\/10.1016\/j.ijsu.2020.03.036 (2020).","journal-title":"Int. J. Surg."},{"key":"98253_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6019","author":"JM Sanders","year":"2020","unstructured":"Sanders, J. M., Monogue, M. L., Jodlowski, T. Z. & Cutrell, J. B. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA https:\/\/doi.org\/10.1001\/jama.2020.6019 (2020).","journal-title":"JAMA"},{"key":"98253_CR3","doi-asserted-by":"publisher","first-page":"100007","DOI":"10.1016\/j.xinn.2020.04.007","volume":"1","author":"C Chen","year":"2020","unstructured":"Chen, C. et al. Predicting illness severity and short-term outcomes of COVID-19: A retrospective cohort study in China. Innovation 1, 100007\u2013100007. https:\/\/doi.org\/10.1016\/j.xinn.2020.04.007 (2020).","journal-title":"Innovation"},{"key":"98253_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.2033","author":"W Liang","year":"2020","unstructured":"Liang, W. et al. Development and validation of a clinical risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.2033 (2020).","journal-title":"JAMA Intern. Med."},{"key":"98253_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.117788","volume":"254","author":"M Kermali","year":"2020","unstructured":"Kermali, M., Khalsa, R. K., Pillai, K., Ismail, Z. & Harky, A. The role of biomarkers in diagnosis of COVID-19\u2014A systematic review. Life Sci. 254, 117788. https:\/\/doi.org\/10.1016\/j.lfs.2020.117788 (2020).","journal-title":"Life Sci."},{"key":"98253_CR6","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.0c00326","author":"AD Whetton","year":"2020","unstructured":"Whetton, A. D., Preston, G. W., Abubeker, S. & Geifman, N. Proteomics and informatics for understanding phases and identifying biomarkers in COVID-19 disease. J. Proteome Res. https:\/\/doi.org\/10.1021\/acs.jproteome.0c00326 (2020).","journal-title":"J. Proteome Res."},{"key":"98253_CR7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cell.2020.05.032","volume":"182","author":"B Shen","year":"2020","unstructured":"Shen, B. et al. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 182, 59-72 e15. https:\/\/doi.org\/10.1016\/j.cell.2020.05.032 (2020).","journal-title":"Cell"},{"key":"98253_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cels.2020.05.012","volume":"11","author":"CB Messner","year":"2020","unstructured":"Messner, C. B. et al. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst. 11, 11-24 e14. https:\/\/doi.org\/10.1016\/j.cels.2020.05.012 (2020).","journal-title":"Cell Syst."},{"key":"98253_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-020-00333-1","volume":"5","author":"B Di","year":"2020","unstructured":"Di, B. et al. Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics. Signal Transduct. Target Ther. 5, 217. https:\/\/doi.org\/10.1038\/s41392-020-00333-1 (2020).","journal-title":"Signal Transduct. Target Ther."},{"key":"98253_CR10","doi-asserted-by":"publisher","first-page":"22418","DOI":"10.1038\/s41598-020-80120-8","volume":"10","author":"J Park","year":"2020","unstructured":"Park, J. et al. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci. Rep. 10, 22418. https:\/\/doi.org\/10.1038\/s41598-020-80120-8 (2020).","journal-title":"Sci. Rep."},{"key":"98253_CR11","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1007\/s00011-020-01372-8","volume":"69","author":"GH Meftahi","year":"2020","unstructured":"Meftahi, G. H., Jangravi, Z., Sahraei, H. & Bahari, Z. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: The contribution of \u201cinflame-aging\u201d. Inflamm. Res. 69, 825\u2013839. https:\/\/doi.org\/10.1007\/s00011-020-01372-8 (2020).","journal-title":"Inflamm. Res."},{"key":"98253_CR12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/s41577-020-0312-7","volume":"20","author":"G Schett","year":"2020","unstructured":"Schett, G., Sticherling, M. & Neurath, M. F. COVID-19: Risk for cytokine targeting in chronic inflammatory diseases?. Nat. Rev. Immunol. 20, 271\u2013272. https:\/\/doi.org\/10.1038\/s41577-020-0312-7 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"98253_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","volume":"17","author":"M Nishiga","year":"2020","unstructured":"Nishiga, M., Wang, D. W., Han, Y., Lewis, D. B. & Wu, J. C. COVID-19 and cardiovascular disease: From basic mechanisms to clinical perspectives. Nat. Rev. Cardiol. 17, 543\u2013558. https:\/\/doi.org\/10.1038\/s41569-020-0413-9 (2020).","journal-title":"Nat. Rev. Cardiol."},{"key":"98253_CR14","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/eji.202048693","volume":"50","author":"V Schijns","year":"2020","unstructured":"Schijns, V. & Lavelle, E. C. Prevention and treatment of COVID-19 disease by controlled modulation of innate immunity. Eur. J. Immunol. 50, 932\u2013938. https:\/\/doi.org\/10.1002\/eji.202048693 (2020).","journal-title":"Eur. J. Immunol."},{"key":"98253_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5 (2020).","journal-title":"Lancet"},{"key":"98253_CR16","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"MZ Tay","year":"2020","unstructured":"Tay, M. Z., Poh, C. M., Renia, L., MacAry, P. A. & Ng, L. F. P. The trinity of COVID-19: Immunity, inflammation and intervention. Nat. Rev. Immunol. 20, 363\u2013374. https:\/\/doi.org\/10.1038\/s41577-020-0311-8 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"98253_CR17","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.3313","author":"P Sinha","year":"2020","unstructured":"Sinha, P., Matthay, M. A. & Calfee, C. S. Is a \u201cCytokine Storm\u201d relevant to COVID-19?. JAMA Intern. Med. https:\/\/doi.org\/10.1001\/jamainternmed.2020.3313 (2020).","journal-title":"JAMA Intern. Med."},{"key":"98253_CR18","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.17052","author":"M Kox","year":"2020","unstructured":"Kox, M., Waalders, N. J. B., Kooistra, E. J., Gerretsen, J. & Pickkers, P. Cytokine levels in critically ill patients with COVID-19 and other conditions. JAMA https:\/\/doi.org\/10.1001\/jama.2020.17052 (2020).","journal-title":"JAMA"},{"key":"98253_CR19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/j.1365-2249.2007.03561.x","volume":"151","author":"JS Johansen","year":"2008","unstructured":"Johansen, J. S. et al. High serum YKL-40 level in a cohort of octogenarians is associated with increased risk of all-cause mortality. Clin. Exp. Immunol. 151, 260\u2013266. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03561.x (2008).","journal-title":"Clin. Exp. Immunol."},{"key":"98253_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ijcard.2009.01.043","volume":"143","author":"CN Rathcke","year":"2010","unstructured":"Rathcke, C. N. et al. Low grade inflammation as measured by levels of YKL-40: Association with an increased overall and cardiovascular mortality rate in an elderly population. Int. J. Cardiol. 143, 35\u201342. https:\/\/doi.org\/10.1016\/j.ijcard.2009.01.043 (2010).","journal-title":"Int. J. Cardiol."},{"key":"98253_CR21","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.rmed.2010.02.026","volume":"104","author":"K Furuhashi","year":"2010","unstructured":"Furuhashi, K. et al. Increased expression of YKL-40, a chitinase-like protein, in serum and lung of patients with idiopathic pulmonary fibrosis. Respir. Med. 104, 1204\u20131210. https:\/\/doi.org\/10.1016\/j.rmed.2010.02.026 (2010).","journal-title":"Respir. Med."},{"key":"98253_CR22","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12931-016-0338-3","volume":"17","author":"T Lai","year":"2016","unstructured":"Lai, T. et al. YKL-40 expression in chronic obstructive pulmonary disease: Relation to acute exacerbations and airway remodeling. Respir. Res. 17, 31. https:\/\/doi.org\/10.1186\/s12931-016-0338-3 (2016).","journal-title":"Respir. Res."},{"key":"98253_CR23","doi-asserted-by":"publisher","first-page":"885","DOI":"10.2147\/COPD.S236640","volume":"15","author":"N Przysucha","year":"2020","unstructured":"Przysucha, N., Gorska, K. & Krenke, R. Chitinases and chitinase-like proteins in obstructive lung diseases\u2014Current concepts and potential applications. Int. J. Chron. Obstr. Pulm. Dis. 15, 885\u2013899. https:\/\/doi.org\/10.2147\/COPD.S236640 (2020).","journal-title":"Int. J. Chron. Obstr. Pulm. Dis."},{"key":"98253_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/edrv.18.6.0321","volume":"18","author":"S Rajaram","year":"1997","unstructured":"Rajaram, S., Baylink, D. J. & Mohan, S. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions. Endocr. Rev. 18, 801\u2013831. https:\/\/doi.org\/10.1210\/edrv.18.6.0321 (1997).","journal-title":"Endocr. Rev."},{"key":"98253_CR25","doi-asserted-by":"publisher","first-page":"6868","DOI":"10.1073\/pnas.120172697","volume":"97","author":"I Ueki","year":"2000","unstructured":"Ueki, I. et al. Inactivation of the acid labile subunit gene in mice results in mild retardation of postnatal growth despite profound disruptions in the circulating insulin-like growth factor system. Proc. Natl. Acad. Sci. U. S. A. 97, 6868\u20136873. https:\/\/doi.org\/10.1073\/pnas.120172697 (2000).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"98253_CR26","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.1210\/endo.142.10.8427","volume":"142","author":"JV Silha","year":"2001","unstructured":"Silha, J. V. et al. Overexpression of the acid-labile subunit of the IGF ternary complex in transgenic mice. Endocrinology 142, 4305\u20134313. https:\/\/doi.org\/10.1210\/endo.142.10.8427 (2001).","journal-title":"Endocrinology"},{"key":"98253_CR27","doi-asserted-by":"publisher","first-page":"6057589","DOI":"10.1155\/2018\/6057589","volume":"2018","author":"Z Wang","year":"2018","unstructured":"Wang, Z. et al. Insulin-like growth factor-1 signaling in lung development and inflammatory lung diseases. Biomed. Res. Int. 2018, 6057589. https:\/\/doi.org\/10.1155\/2018\/6057589 (2018).","journal-title":"Biomed. Res. Int."},{"key":"98253_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1530\/EJE-11-0778","volume":"166","author":"AM Ahasic","year":"2012","unstructured":"Ahasic, A. M. et al. IGF1 and IGFBP3 in acute respiratory distress syndrome. Eur. J. Endocrinol. 166, 121\u2013129. https:\/\/doi.org\/10.1530\/EJE-11-0778 (2012).","journal-title":"Eur. J. Endocrinol."},{"key":"98253_CR29","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1097\/CCM.0000000000001314","volume":"43","author":"AM Ahasic","year":"2015","unstructured":"Ahasic, A. M. et al. Predictors of circulating insulin-like growth factor-1 and insulin-like growth factor-binding protein-3 in critical illness. Crit. Care Med. 43, 2651\u20132659. https:\/\/doi.org\/10.1097\/CCM.0000000000001314 (2015).","journal-title":"Crit. Care Med."},{"key":"98253_CR30","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10654-020-00709-1","volume":"36","author":"X Fan","year":"2021","unstructured":"Fan, X. et al. Pre-diagnostic circulating concentrations of insulin-like growth factor-1 and risk of COVID-19 mortality: results from UK Biobank. Eur. J. Epidemiol. 36, 311-318. https:\/\/doi.org\/10.1007\/s10654-020-00709-1 (2021).","journal-title":"Eur. J. Epidemiol."},{"key":"98253_CR31","doi-asserted-by":"publisher","first-page":"43732","DOI":"10.1038\/srep43732","volume":"7","author":"Y Kimura","year":"2017","unstructured":"Kimura, Y. et al. Identification of candidate diagnostic serum biomarkers for Kawasaki disease using proteomic analysis. Sci. Rep. 7, 43732. https:\/\/doi.org\/10.1038\/srep43732 (2017).","journal-title":"Sci. Rep."},{"key":"98253_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0023385","volume":"6","author":"Y Ando","year":"2011","unstructured":"Ando, Y. et al. Nuclear pore complex protein mediated nuclear localization of dicer protein in human cells. PLoS\u00a0One 6, e23385. https:\/\/doi.org\/10.1371\/journal.pone.0023385 (2011).","journal-title":"PLoS\u00a0One"},{"key":"98253_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1477-5956-6-9","volume":"6","author":"J Chenau","year":"2008","unstructured":"Chenau, J., Michelland, S., Sidibe, J. & Seve, M. Peptides OFFGEL electrophoresis: A suitable pre-analytical step for complex eukaryotic samples fractionation compatible with quantitative iTRAQ labeling. Proteome Sci. 6, 9. https:\/\/doi.org\/10.1186\/1477-5956-6-9 (2008).","journal-title":"Proteome Sci."},{"key":"98253_CR34","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nprot.2007.261","volume":"2","author":"J Rappsilber","year":"2007","unstructured":"Rappsilber, J., Mann, M. & Ishihama, Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat. Protoc. 2, 1896\u20131906. https:\/\/doi.org\/10.1038\/nprot.2007.261 (2007).","journal-title":"Nat. Protoc."},{"key":"98253_CR35","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","volume":"13","author":"S Tyanova","year":"2016","unstructured":"Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731\u2013740. https:\/\/doi.org\/10.1038\/nmeth.3901 (2016).","journal-title":"Nat. Methods"},{"key":"98253_CR36","doi-asserted-by":"publisher","first-page":"D433","DOI":"10.1093\/nar\/gki005","volume":"33","author":"C von Mering","year":"2005","unstructured":"von Mering, C. et al. STRING: Known and predicted protein\u2013protein associations, integrated and transferred across organisms. Nucleic Acids Res. 33, D433-437. https:\/\/doi.org\/10.1093\/nar\/gki005 (2005).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98253-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98253-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:28:42Z","timestamp":1670084922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-98253-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,19]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["98253"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-98253-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,19]]},"assertion":[{"value":"27 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20638"}}